PGEN Latest Press Releases

-- October 28, 2026 --

Precigen to Announce Third Quarter 2026 Financial Results and Provide Business Updates on November 4 PRNewswire 4:06 PM

-- September 21, 2026 --

Precigen Receives FDA Platform Technology Designation for AdenoVerse Platform PRNewswire 7:00 AM

-- August 25, 2026 --

Precigen's Strong Second Quarter Signals Significant Growth, Validates AdenoVerse Platform; PRGN-2009 Advances in HPV-Driven Cancers ACCESS Newswire 7:00 AM

-- August 4, 2026 --

Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth PRNewswire 4:01 PM

-- July 21, 2026 --

Precigen to Announce Second Quarter 2026 Financial Results and Provide Business Updates on August 4 PRNewswire 8:01 AM

-- June 15, 2026 --

Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging ACCESS Newswire 6:40 AM

-- June 11, 2026 --

Precigen and the Recurrent Respiratory Papillomatosis Foundation Recognize International RRP Awareness Day by Elevating Patient and Community Voices PRNewswire 8:00 AM

Market Data Delayed 15 Minutes